(Q61443994)

1

0 references

Sunny Himansu

2

0 references

Bryant M Foreman

3

0 references

Gregory D Ebel

4

0 references

Theodore C Pierson

Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection

5

0 references

language of work or name

English

0 references

publication date

18 December 2018

0 references

published in

Cell Reports

0 references

volume

25

0 references

issue

12

0 references

page(s)

3382-3392.e3

0 references

cites work

1 reference

12 December 2020

Sequence of the genes encoding the structural proteins of the low-virulence tick-borne flaviviruses Langat TP21 and Yelantsev

1 reference

12 December 2020

Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D Vaccine

1 reference

12 December 2020

Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form

1 reference

12 December 2020

Complete genomic sequence of Powassan virus: evaluation of genetic elements in tick-borne versus mosquito-borne flaviviruses

1 reference

12 December 2020

Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis

1 reference

12 December 2020

A Focus of Deer Tick Virus Transmission in the Northcentral United States

1 reference

12 December 2020

Infectious cDNA clones of Langat tick-borne flavivirus that differ from their parent in peripheral neurovirulence

1 reference

12 December 2020

West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays

1 reference

12 December 2020

Phylogeny of North American Powassan virus

1 reference

12 December 2020

Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine

1 reference

12 December 2020

Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.

1 reference

12 December 2020

Tick-borne encephalitis

1 reference

12 December 2020

Powassan virus: isolation of virus from a fatal case of encephalitis

1 reference

12 December 2020

Isolation of a virus closely related to Powassan virus from Dermacentor andersoni collected along North Cache la Poudre River, Colo.

1 reference

12 December 2020

An animal model for the tickborne flavivirus--Omsk hemorrhagic fever virus

1 reference

12 December 2020

Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru

1 reference

12 December 2020

A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection

1 reference

12 December 2020

Blocking Monoclonal Antibodies Specific for Mouse IFN-α/β Receptor Subunit 1 (IFNAR-1) from Mice Immunized by In Vivo Hydrodynamic Transfection

1 reference

12 December 2020

Genetic characterization of tick-borne flaviviruses: new insights into evolution, pathogenetic determinants and taxonomy

1 reference

12 December 2020

Field effectiveness of vaccination against tick-borne encephalitis

1 reference

12 December 2020

Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation

1 reference

12 December 2020

Stable prevalence of Powassan virus in Ixodes scapularis in a northern Wisconsin focus.

1 reference

12 December 2020

Characterization of Powassan viruses from Far Eastern Russia.

1 reference

12 December 2020

Impact of Quaternary Organization on the Antigenic Structure of the Tick-Borne Encephalitis Virus Envelope Glycoprotein E

1 reference

12 December 2020

Update on Powassan virus: emergence of a North American tick-borne flavivirus

1 reference

12 December 2020

Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants

1 reference

12 December 2020

Prevalence and genetic characterization of Powassan virus strains infecting Ixodes scapularis in Connecticut

1 reference

12 December 2020

Fatal neurological respiratory insufficiency is common among viral encephalitides

1 reference

12 December 2020

A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available

1 reference

12 December 2020

Propagation, quantification, detection, and storage of West Nile virus

1 reference

12 December 2020

The prevalence of zoonotic tick-borne pathogens in Ixodes scapularis collected in the Hudson Valley, New York State

1 reference

12 December 2020

Pseudo-infectious reporter virus particles for measuring antibody-mediated neutralization and enhancement of dengue virus infection

1 reference

12 December 2020

Type I interferon protects mice from fatal neurotropic infection with Langat virus by systemic and local antiviral responses.

1 reference

12 December 2020

Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination

1 reference

12 December 2020

Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host

1 reference

12 December 2020

Tick Saliva Enhances Powassan Virus Transmission to the Host, Influencing Its Dissemination and the Course of Disease

1 reference

12 December 2020

Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin

1 reference

12 December 2020

Structural Basis of Zika Virus-Specific Antibody Protection

1 reference

12 December 2020

Spinal Cord Ventral Horns and Lymphoid Organ Involvement in Powassan Virus Infection in a Mouse Model

1 reference

12 December 2020

Rapid development of a DNA vaccine for Zika virus

1 reference

12 December 2020

Modeling Powassan virus infection in Peromyscus leucopus, a natural host.

1 reference

12 December 2020

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

1 reference

12 December 2020

Modified mRNA Vaccines Protect against Zika Virus Infection

1 reference

12 December 2020

Characteristics of far eastern strains of tick-borne encephalitis virus.

1 reference

12 December 2020

Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection

1 reference

12 December 2020

Powassan/Deer Tick Virus and Borrelia Burgdorferi Infection in Wisconsin Tick Populations.

1 reference

12 December 2020

Powassan Virus: An Emerging Arbovirus of Public Health Concern in North America

1 reference

12 December 2020

Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease

1 reference

12 December 2020

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

1 reference

12 December 2020

Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection

1 reference

12 December 2020

1 reference

12 December 2020

Longitudinal Analysis of Antibody Cross-Neutralization Following Zika and Dengue Virus Infection in Asia and the Americas.

1 reference

12 December 2020

Powassan Virus Disease in the United States, 2006-2016

1 reference

12 December 2020

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.

1 reference

12 December 2020

A VSV-based Zika virus vaccine protects mice from lethal challenge

1 reference

12 December 2020